Podcasts about fda approved

Steve Marchese, the CEO of LightStim, the largest LED Medical Device Manufacturer in the US, shares insights, truths, and myths regarding the benefits of true "light stimulation". Steve Marchese joins Dr. Haley to discuss how what people call "red light therapy" is more than just one color. It also includes blue and infrared, which are crucial for seeing full benefits. Listen to the full podcast to learn more about these alternative therapies.RESOURCES:https://drhaley.com/truth-about-red-light-therapy/https://lightstim.com/https://www.facebook.com/lightstimhttps://www.instagram.com/lightstimhttps://www.linkedin.com/company/lightstim/https://www.youtube.com/LightStimTIMESTAMPS:00:00 Intro Snip00:33 Coupon Announcement for use at Lightstim.com02:38 Introduce Steve Marchese CEO of Lightstim04:02 Why "light therapy" should be called "light stimulation"04:33 What is light therapy and light stimulation used for?07:52 Do you treat just the injury with light stimulation or the whole body when there is an injury?11:22 How can you tell if you are buying a quality light therapy device and if it does what it is supposed to do?13:48 What is the difference between FDA Registered and FDA Cleared or FDA Approved?15:25 How can we use multiple wavelengths at the same time without cancelling out the wavelengths?18:00 How close should you be to the LED light source for efficacy?20:10 What happens when you use an acrylic layer for the patient to lay on?21:58 What is the FDA's test for efficacy?26:00 What did the FTC warn the health and wellness industry about red light therapy?27:22 What did a law firm do recently regarding an FDA "EXEMPTION" in January of 2021?28:25 What did the "FDA Exemption" actually require?30:00 What were the 2 additional requirements to qualify for the exemption?33:16 What is the difference between red laser treatment and red led treatments?35:20 What makes red light the right color and wavelength?37:17 What do the infared radiators in the sauna tent do?40:40 Does insurance pay for light stimulation?41:10 How does light stimulation affect blood pressure?43:04 Where can we go to try one of the red light stimulation beds?44:24 Us there a difference in the output between battery and corded handheld units?46:31 Where are the LightStim products manufactured?49:15 Where should people go for more information?50:15 What are some of the myths of red light therapy?52:25 What are the general principles between using red, blue, and amber?56:40 How to use an aloe vera leaf for anti-aging57:25 How to use a lightstim unit to improve the performance of skin products

RESOURCES & LINKS  Watch a message from Barbara HERE  Check out the Osteoboost Official Website HERE  Visit the Bone Health & Osteoporosis Foundation Website HERE  EPISODE UPDATE This is a replay of our March episode with Laura Yecies, CEO of Osteoboost. Since our original conversation aired, I have started using the Osteoboost vibration belt—30 minutes daily—as part of my bone health routine.  In this conversation, Laura and I discuss Osteoboost, an FDA-approved device using NASA-inspired vibration therapy to combat bone loss. Laura explains how the technology works, its impressive clinical results (85% reduction in spinal bone loss), and who benefits most.  KEY TAKEAWAYS  Early intervention in bone health is crucial; hip fractures pose significant risks  Osteoboost uses precision vibration technology inspired by NASA research  The device works best when combined with nutrition and exercise  Particularly effective for postmenopausal women with osteopenia  FDA-approved and backed by clinical studies showing microarchitectural improvements  Telehealth options are available for prescriptions  Future studies planned for osteoporosis applications  Note: For informational purposes only. Consult your healthcare provider before starting any new health regimen.  Take a listen—and don't forget to follow the show so you never miss an episode.    If you're enjoying Age Better, I'd be so grateful if you left a quick review wherever you listen.     And if there's a topic or question you'd love for me to cover in a future episode, send a note to agebetterpodcast@gmail.com -- I love hearing from you!   Learn more about your ad choices. Visit megaphone.fm/adchoices

BUFFALO, NY – August 15, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on August 13, 2025, titled “Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assay.” In this study, first authors Valeriy Domenyuk and Kasey Benson, along with corresponding author David Spetzler from Caris Life Sciences in Irving, Texas, introduce MI Cancer Seek, an FDA-approved test designed to deliver comprehensive tumor profiling. MI Cancer Seek demonstrated strong concordance with other FDA-approved companion diagnostics and serves as a powerful tool to guide treatment decisions in both adult and pediatric cancer patients. Cancer remains one of the most complex and diverse diseases to treat. With many targeted therapies currently FDA-approved, selecting the right one for a specific patient requires detailed genetic insights. MI Cancer Seek addresses this need by analyzing both DNA and RNA from a single tumor sample. The tool identifies key biomarkers linked to FDA-approved treatments for several major cancers, including breast, lung, colon, melanoma, and endometrial cancers. One of the most significant strengths of MI Cancer Seek is its ability to deliver accurate and reliable results from minimal tissue input (50 ng). Even when analyzing formalin-fixed paraffin-embedded samples, which are widely used but often degraded, the test maintained high levels of accuracy. It successfully detected important genetic alterations such as PIK3CA, EGFR, BRAF, and KRAS/NRAS mutations and measured tumor mutational burden (TMB) and microsatellite instability (MSI), both of which are key indicators for immunotherapy response. In clinical comparisons, the test achieved over 97% agreement with other FDA-approved diagnostic tools, confirming its reliability in detecting critical biomarkers. Notably, it showed near-perfect accuracy in identifying MSI status in colorectal and endometrial cancers. The researchers also demonstrated that the test maintains precision across different lab conditions and varying DNA input levels, confirming its robustness for routine clinical use. Beyond its role as a companion diagnostic, MI Cancer Seek incorporates additional features developed under its predecessor, MI Tumor Seek Hybrid. These include detection of homologous recombination deficiency, structural variants, and cancer-related viruses. It also includes advanced tools such as the Genomic Probability Score for identifying the tissue of origin in cancers of unknown primary, as well as a gene signature to guide first-line chemotherapy in colorectal cancer. “One limitation to be considered is the low PPA for ERBB2 CNA detection.” By offering deeper genetic insights from a single, small sample, MI Cancer Seek has the potential to streamline diagnostics, reduce testing costs, and connect patients to effective therapies more quickly. As precision medicine continues to expand, this assay stands out as a comprehensive and efficient solution for meeting the evolving needs of modern oncology. DOI - https://doi.org/10.18632/oncotarget.28761 Correspondence to - David Spetzler - dspetzler@carisls.com Video short - https://www.youtube.com/watch?v=D4hd2FxCYY8 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Dr. Aliaksandr Ramaniuk and Nicole Piriak discuss the importance of smoking cessation, the dangers of vaping, and various replacement therapies. 

Story at-a-glance Results of a two-year investigation found that the U.S. Food and Drug Administration (FDA) approved nearly 75% of new drugs between 2013 and 2022 without meeting its own basic standards Some cancer and Alzheimer's drugs were fast-tracked using surrogate markers like tumor shrinkage or protein levels, not real improvements in survival, memory, or function Dangerous side effects — including brain inflammation, hemorrhage, and blindness — were linked to drugs approved on minimal or flawed data, with thousands of deaths occurring each year The reporters created a searchable database on FDA drug approvals made between 2013 and 2022 — use it to check if any of your prescriptions meet the four scientific standards Always ask if a drug shows real-world benefits, look up its approval history, wait on new drugs, review your prescriptions, and work with a doctor who questions the system

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking? Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 69 Can Topiramate Replace FDA-Approved Medications for Alcohol Use Disorder?

Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopedics at Feinberg School of Medicine, joins Lisa Dent to discuss ivermectin. Dr. Elliot explains, is prescribed to treat parasitic infections. He shares when its prescribed, and whether or not ivermectin is FDA approved.

Send us a textWhy do so many digital pathology tools stall before they ever reach patients? In this USCAP 2025 special sponsored by Muse Microscopy, I talk with Esther Abels, founder of SolarisRTC, regulatory strategist, and the force behind the first FDA-cleared whole slide imaging system.We break down what startups and established companies must do from day one to succeedbin getting their devices through the FDA. Hint: regulatory strategy isn't a final step—it's your starting line.

This blog was created using Notebook LM.This podcast describes the FDA approval of Suzetrigine, a novel non-opioid medication intended for moderate to severe pain. It explains that Suzetrigine operates by inhibiting voltage-gated sodium channel 1.8, which are crucial for transmitting pain signals. 

In this enlightening episode, we sit down with Laura Yecies to discuss Osteoboost, the first and only FDA-cleared, drug-free prescription medical device designed to treat osteopenia in postmenopausal women. Dr. Yecies shares insights into the clinical research behind Osteoboost, its development inspired by NASA-funded studies, and the importance of proactive bone health management. Key Topics Covered: The Innovation Behind Osteoboost: Understanding how precision vibration therapy targets the spine and hips to reduce bone density and strength loss. (Osteoboost) Clinical Efficacy: Discussing the results from a double-blind, placebo-controlled clinical trial showing up to an 85% reduction in spine bone density loss and an 83% reduction in bone strength loss among consistent users. (MedicalEconomics) Importance of Early Intervention: Exploring why addressing bone health before the onset of osteoporosis is crucial, especially for postmenopausal women. User Experience: Highlighting the ease of incorporating Osteoboost into daily routines, with just 30 minutes of use per day during activities like walking or cooking. (MedicalEconomics) Broader Implications: Considering how Osteoboost fits into the larger conversation about aging, mobility, and long-term health. Resources & Links: Learn more about Osteoboost: Osteoboost Clinical Trial Details: Osteoboost Clinical Trial Results FDA Clearance Information: FDA Grants Clearance to Bone Health Technologies' Wearable Device for Osteopenia Guest Bio: Laura Yecies is the CEO of Osteoboost Health, Inc., the company behind the first and only FDA-cleared, non-drug wearable for low bone density. She has over 30 years of leadership experience in the technology and medical sectors. Prior to Osteoboost, she was CEO of NeuroSync, Catch (acq. by Apple), and SugarSync. Laura is also an active advisor and executive coach for early-stage digital health and therapeutics companies, focusing on supporting women founders. She holds an MBA from Harvard, MSFS from Georgetown, and AB from Dartmouth.

Eating crickets and meat grown in a lab with cancer-like cells - WHO APPROVED THAT?! Scott Tips, president of the National Health Federation (NHF) and internationally recognized health freedom attorney, joins host, Jamie Belz, to help us understand the deeper mechanisms of Codex Alimentarius, the World Trade Organization (WTO), and the global regulatory web that threatens access to nutrient-dense food, natural health remedies, and therapeutic supplements.   As the only health-freedom organization with official INGO (International Non-Governmental Organization) status at Codex, NHF is uniquely positioned to stand up for the public's right to safe, informed, and autonomous healthcare choices on the global stage.   Over the last 70 years, NHF has defended medical choice and challenged the federal government's overreach into nutrition, supplementation, and holistic healing.   Some quick topics/snippets from this episode: Codex creates international food law—affecting everything from vitamin dosage limits to whether or not your meat contains drug residues. Most people don't even know Codex exists. And yet, decisions made there determine what shows up in your grocery cart, your supplement bottle, and your child's plate. The U.S. can now force genetically modified foods into countries that don't want them — not through diplomacy, but through international tribunals using Codex standards as their weapon. Ractopamine is a drug with zero therapeutic value. It makes animals fatter, faster — but it's banned in the EU, China, and Russia. In the U.S., you're probably eating it. When you hear ‘scientific consensus,' be cautious. The phrase is used to bulldoze public concern. You can be banned for calling out corruption at Codex. At CODEX, NHF is the only one defending your right to natural health freedom. The EU, Russia, even Iran — they've stood up for consumer safety at Codex more than the U.S. delegates have. The scary thing isn't just what the FDA is doing. It's how many people still trust them, blindly — even when their actions have harmed more people than every U.S. war combined. We need advocacy from the ground up. Most parents feeding their kids toxic food don't even know it — because the truth has been buried. “Frankenmeat”, insect protein, and natural flavoring cover-ups, all of which bypass transparent labeling laws while being quietly introduced into the food supply. They're trying to outlaw homeopathy—while promoting lab-grown meat and insect protein as sustainable alternatives. We don't want to be right. We want to get it right.   “Unless we put medical freedom into the Constitution, the time will come when medicine will organize into an undercover dictatorship… To restrict the art of healing to one class of men and deny equal privileges to others will constitute the Bastille of medical science. All such laws are un-American and despotic.” - Dr. Benjamin Rush, Declaration of Independence signator and Surgeon General of the Continental Army   "If people let the government decide what foods they eat and what medicines they take, their bodies will soon be in as sorry a state as the souls of those who live under tyranny.” - Thomas Jefferson   TAKE ACTION:  Join the National Health Federation for only $45/year to support international advocacy at Codex and receive the quarterly NHF magazine. This low-cost membership helps fund independent watchdog efforts that no other organization is legally authorized to perform at the global level. ⁠JOIN HERE⁠   Other mentions: ⁠⁠Ep 034: Fight For Your Right To Health Freedom⁠⁠ ⁠The HighWire report exposing Peter Marks and vaccine data suppression⁠    Health freedom is necessary. As government and corporate interests grow more entangled, grassroots advocacy is no longer optional. It's essential. Join the NHF and become part of the movement to reclaim sovereignty over what we eat, how we heal, and what we're allowed to know.    

May 20, 2025 ~ A new FDA-approved blood test, the Shield test, is available for colon cancer screening for people 45 and older. Guardian VP of Clinical Development, Dr. Sam Asgarian, talks with Lloyd, Jamie, and Chris about this alternative test to traditional methods and simplifying the screening process.

How Gene Editing Could Transform Global Pork HealthJoin us for an exclusive conversation with PIC as we explore the historic FDA approval of the first gene-edited PRRS-resistant pig. Discover what this milestone means for the future of pork production, how gene editing differs from traditionalGMOs, and why this matters for both producers and consumers. We also dive into the potential $1.2 billion impact on global herd health and what's next as PIC plans for a responsible international rollout.

In this episode of Plastic Surgery 90210, Dr. J. Timothy Katzen and Ariel 90210 break down the critical differences between illegal silicone injections (also known as “butt shots” or “permanent filler”) and FDA-approved silicone implants used in plastic surgery. Learn why free silicone injections are extremely dangerous, how they can migrate through the body, and the life-threatening complications they cause—from silicone embolism to kidney failure.Dr. Katzen shares real patient stories, including tragic cases of underground injections gone wrong, the formation of scar tissue (bobas), and why liquid silicone cannot be safely removed. The discussion also covers safer alternatives for buttock enhancement, including BBLs, butt implants, Sculptra, and FDA-approved fillers.

In this episode, Dr. Rohrich is joined by Dr. Steven Faigan to discuss Letybo, the newest FDA-approved neuromodulator from Korea.

*In this Episode, Dr. Lisa Faast discusses the FDA-approved product Ycanth, the only approved cantharidin treatment for molluscum contagiosum.** **Show Notes:** 1. **Introduction to the Podcast and Lisa Faast** [0:00] 2. **Overview of Cantharidin and Its Uses** [1:47] 3. **Development and Features of Ycanth** [3:16] 4. **Benefits and Availability of Ycanth** [6:22] 5. **Ordering and Billing Process for Ycanth** [9:14] 6. **Conclusion and Additional Resources** [11:01]   Websites Mentioned: https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

Send us a message with this link, we would love to hear from you. Standard message rates may apply.The meteoric rise in demand for weight loss drugs has created widespread shortages, leading to the emergence of compounding pharmacies as an alternative source for these medications.• Compounding pharmacies create custom medications by combining, mixing, or altering ingredients to meet specific needs• Unlike FDA-approved medications, compounded drugs don't undergo the same rigorous safety and effectiveness reviews• Dosing errors with compounded weight loss medications have led to serious adverse events requiring hospitalization• Confusion between units, milliliters, and milligrams contributes to potentially dangerous dosing mistakes• Some compounding pharmacies add unproven ingredients like vitamins, L-carnitine, and NAD to their formulations• The long half-life of these medications (about one week) means overdose symptoms can persist for extended periods• Pharmaceutical companies have responded with direct-to-consumer models offering FDA-approved versions at reduced prices• Eli Lilly now offers Zepbound in vial form for approximately $499/month versus $1000+ for pen versions• Novo Nordisk's NovaCare pharmacy provides direct-to-patient delivery of Wegovy single-dose pens at similar price pointsPlease talk to your healthcare provider about what option might be right for you, as these medications require careful consideration and proper dosing is essential for safety.Support the showProduction and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

RESOURCES & LINKS  - Osteoboost Official Website  - Video: Laura Yecies Discussing Osteoboost  - Bone Health & Osteoporosis Foundation Website  - Email questions to agebetterpodcast@gmail.com   AGE BETTER host Barbara Hannah Grufferman and Laura Yecies, CEO of Osteoboost, discuss Osteoboost, an FDA-approved device using NASA-inspired vibration therapy to combat bone loss. Laura explains how the technology works, its impressive clinical results (85% reduction in spinal bone loss), and who benefits most.     KEY TAKEAWAYS  - Early intervention in bone health is crucial; hip fractures pose significant risks  - Osteoboost uses precision vibration technology inspired by NASA research  - The device works best when combined with nutrition and exercise  - Particularly effective for postmenopausal women with osteopenia  - FDA-approved and backed by clinical studies showing microarchitectural improvements  - Telehealth options are available for prescriptions  - Future studies planned for osteoporosis applications  *Note: For informational purposes only. Consult your healthcare provider before starting any new health regimen.*  Learn more about your ad choices. Visit megaphone.fm/adchoices

Shawn Ryan Show: Read the notes at at podcastnotes.org. Don't forget to subscribe for free to our newsletter, the top 10 ideas of the week, every Monday --------- Paul Saladino, MD, is a double board-certified physician and a prominent advocate for an animal-based diet, known for his controversial views on nutrition and health. He graduated from the University of Arizona College of Medicine and completed his residency at the University of Washington. Saladino is the author of *The Carnivore Code* and *The Carnivore Code Cookbook*, where he argues that many chronic illnesses are linked to poor dietary choices and can be prevented or reversed through proper nutrition. His professional philosophy emphasizes questioning mainstream medical narratives, focusing instead on optimal health through dietary changes. In addition to his writing, Saladino hosts the *Fundamental Health* podcast, where he engages with various experts to discuss health optimization. He co-founded Lineage Provisions, which produces high-quality air-dried meat snacks, and Heart & Soil, offering desiccated organ supplements aimed at enhancing nutrient intake. Recently, he has been involved in projects like a collaboration with Raw Farm USA to create a raw kefir smoothie at Erewhon Market, further promoting his vision of ancestral nutrition and wellness through innovative products. Shawn Ryan Show Sponsors: https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner https://amac.us/srs https://meetfabric.com/shawn https://americanfinancing.net/srs | 866-781-8900 | NMLS 182334, www.nmlsconsumeraccess.org https://hillsdale.edu/srs https://patriotmobile.com/srs | 972-PATRIOT This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. https://helixsleep.com/srs https://rocketmoney.com/srs https://prizepicks.onelink.me/LME0/SRS https://blackbuffalo.com Paul Saladino Links: Website - https://www.ABNRF.org Instagram - https://www.instagram.com/paulsaladinomd/?hl=en X - https://x.com/paulsaladinomd TikTok - https://www.tiktok.com/@paulsaladinomd2 YouTube - https://www.youtube.com/c/PaulSaladinoMD Heart & Soil - https://heartandsoil.co/ Lineage Provisions - https://lineageprovisions.com/ShawnRyan Learn more about your ad choices. Visit podcastchoices.com/adchoices

Shawn Ryan Show Intro  We are the only species that have forgotten what we are biologically-programmed to eat Metabolic dysfunction, which exists on a continuum, underlies 90% of chronic illness; becoming metabolically healthy through diet and lifestyle change can cure most chronic illnesses Every year, the government sends out $112 billion in food stamps, which serves an average of 42 million people monthly – about 12% of the U.S. populationAbout 70% of this budget is spent on junk food, and about 10% of it – $12 billion – is spent on soda Additives in ultra-processed foods impair our ability to make energy from them; they are poisonous to our metabolism and to the very things that give us life as humans! There is more to the story than calories: The ingredients in these processed foods are poisonous to humans; the quality of the “calories in” impacts the body's ability to do “calories out” Consuming monogastric animals such as pork and chicken is problematic for humans because these animals accumulate polyunsaturated fats, which are harmful to humans; ruminants are better for human consumption In the 1900s, rates of chronic illness were a fraction of what they are today; during this time, about 99% of fat that humans ate were beef tallow, ghee, butter, and lard – there were no seed oils in the human diet! Saturated fats are evolutionary consistent and cardioprotective; consuming excess polyunsaturated fats, like linoleic acid in seed oils, is the true culprit of chronic disease due to their oxidative potential  “If you are insulin sensitive and metabolically healthy, LDL is good for you. It ‘s an immune particle; it's valuable. It's when you become insulin resistant that it becomes a liability because it is part of the causal cascade.”  – Paul Saladino Sugar in fruit is different than processed forms of sugar: There are naturally occurring chemicals in fruit and in honey that mitigate the adverse effects of sugar in the body The solution is simple: We do not need medical breakthroughs to fix our health and cure chronic disease; we just need to return to eating the foods that humans have always eaten Read the full notes @ podcastnotes.orgPaul Saladino, MD, is a double board-certified physician and a prominent advocate for an animal-based diet, known for his controversial views on nutrition and health. He graduated from the University of Arizona College of Medicine and completed his residency at the University of Washington. Saladino is the author of *The Carnivore Code* and *The Carnivore Code Cookbook*, where he argues that many chronic illnesses are linked to poor dietary choices and can be prevented or reversed through proper nutrition. His professional philosophy emphasizes questioning mainstream medical narratives, focusing instead on optimal health through dietary changes. In addition to his writing, Saladino hosts the *Fundamental Health* podcast, where he engages with various experts to discuss health optimization. He co-founded Lineage Provisions, which produces high-quality air-dried meat snacks, and Heart & Soil, offering desiccated organ supplements aimed at enhancing nutrient intake. Recently, he has been involved in projects like a collaboration with Raw Farm USA to create a raw kefir smoothie at Erewhon Market, further promoting his vision of ancestral nutrition and wellness through innovative products. Shawn Ryan Show Sponsors: https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner https://amac.us/srs https://meetfabric.com/shawn https://americanfinancing.net/srs | 866-781-8900 | NMLS 182334, www.nmlsconsumeraccess.org https://hillsdale.edu/srs https://patriotmobile.com/srs | 972-PATRIOT This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. https://helixsleep.com/srs https://rocketmoney.com/srs https://prizepicks.onelink.me/LME0/SRS https://blackbuffalo.com Paul Saladino Links: Website - https://www.ABNRF.org Instagram - https://www.instagram.com/paulsaladinomd/?hl=en X - https://x.com/paulsaladinomd TikTok - https://www.tiktok.com/@paulsaladinomd2 YouTube - https://www.youtube.com/c/PaulSaladinoMD Heart & Soil - https://heartandsoil.co/ Lineage Provisions - https://lineageprovisions.com/ShawnRyan Learn more about your ad choices. Visit podcastchoices.com/adchoices

Paul Saladino, MD, is a double board-certified physician and a prominent advocate for an animal-based diet, known for his controversial views on nutrition and health. He graduated from the University of Arizona College of Medicine and completed his residency at the University of Washington. Saladino is the author of *The Carnivore Code* and *The Carnivore Code Cookbook*, where he argues that many chronic illnesses are linked to poor dietary choices and can be prevented or reversed through proper nutrition. His professional philosophy emphasizes questioning mainstream medical narratives, focusing instead on optimal health through dietary changes. In addition to his writing, Saladino hosts the *Fundamental Health* podcast, where he engages with various experts to discuss health optimization. He co-founded Lineage Provisions, which produces high-quality air-dried meat snacks, and Heart & Soil, offering desiccated organ supplements aimed at enhancing nutrient intake. Recently, he has been involved in projects like a collaboration with Raw Farm USA to create a raw kefir smoothie at Erewhon Market, further promoting his vision of ancestral nutrition and wellness through innovative products. Shawn Ryan Show Sponsors: https://ShawnLikesGold.com | 855-936-GOLD #goldcopartner https://amac.us/srs https://meetfabric.com/shawn https://americanfinancing.net/srs | 866-781-8900 | NMLS 182334, www.nmlsconsumeraccess.org https://hillsdale.edu/srs https://patriotmobile.com/srs | 972-PATRIOT This episode is sponsored by BetterHelp. Give online therapy a try at betterhelp.com/srs and get on your way to being your best self. https://helixsleep.com/srs https://rocketmoney.com/srs https://prizepicks.onelink.me/LME0/SRS https://blackbuffalo.com Paul Saladino Links: Website - https://www.ABNRF.org Instagram - https://www.instagram.com/paulsaladinomd/?hl=en X - https://x.com/paulsaladinomd TikTok - https://www.tiktok.com/@paulsaladinomd2 YouTube - https://www.youtube.com/c/PaulSaladinoMD Heart & Soil - https://heartandsoil.co/ Lineage Provisions - https://lineageprovisions.com/ShawnRyan Learn more about your ad choices. Visit podcastchoices.com/adchoices

Extra Extra, Read all about it! Actually, it's a podcast, Listen all about it!  New Pain Med! New Pain Med! New Non-Opioid Pain Med! Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it????? We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us  

Extra Extra, Read all about it! Actually, it's a podcast, Listen all about it!  New Pain Med! New Pain Med! New Non-Opioid Pain Med! Suzetrigine (Journavx) is now FDA Approved for Moderate to Severe Acute Pain in Adults, but what fun facts come along with it????? We turn to the Simpsons, Brugada, and enjoy some club seats while succinctly reviewing everything there is to know about this new non-opioid pain medication on the Pain Pod! Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us  

Helo & Airline Crash Pt.2, New Pain Drug FDA Approved, Confirmation Highlights & Fake StoriesJoin Matt, Amy and Olivia tonight at 7pm A-BLOCK: Helo and Airline Crash Pt.2B-BLOCK: New Pain Drug FDA ApprovedC-Block: Best Moments From ConfirmationD-Block: Fake StoriesF-Block: Overtime Random StoriesWatch the Live Show on the following channels: linktapgo.com/thedumshowBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-dum-show--6012883/support.

For bird enthusiasts, hearing about the negative impacts of habitat loss on bobwhite quail isn't anything new. In fact, this issue have been largely blamed for North America's shrinking bobwhite population. However, parasites may have a larger effect on wild quail than previously thought, especially in Texas and Oklahoma. “Something happened,” said Dr. Ron Kendall, the founder of Texas Tech's Wildlife Toxicology Lab. “We saw innumerable quail in the summer of 2010. Conditions were perfect. But by that fall, the quail were gone.” That year, biologists, wildlife managers, researchers, and hunters rallied together and launched "Operation Idiopathic Decline." The operation brought together multiple universities. Scientists explored the potential causes of the quail population crash. “We looked at pesticides, environmental contaminants, viruses, bacteria, and parasites,” said Dr. Kendall. “Lo and behold, we saw these parasitic worms called helminths in the birds.” 

Stock market update for January 21, 2025. Check out our Instagram account @TheRundownDaily

BUFFALO, NY - December 30, 2024 – A new #editorial was #published in Oncotarget's Volume 15 on December 24, 2024, titled “Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." Authored by Dr. Wafik S. El-Deiry, Editor-in-Chief of Oncotarget, and Dr. Eli Y. Adashi from Brown University, the article highlights concerns about the risks of a newly approved genetic test for cancer risk. This test, called the “Invitae Common Hereditary Cancers Panel," was approved in 2023 and examines 48 genes linked to inherited cancers, including breast, ovarian, and Lynch syndrome-related cancers. Although the test increases access to genetic information, the authors warn that using it without professional guidance may lead to confusion, stress, and potential harm. One concern is that people can order this test online without consulting healthcare professionals or genetic counselors. Without expert help, users might struggle to understand their results especially if they indicate risks that are unclear or difficult to act on. This can cause unnecessary anxiety and confusion. “The DTC option of germ-line testing for cancer susceptibility should be discouraged given the risks of anxiety, lack of adequate interpretation for variants not strongly associated with cancer, potential for minors to be tested outside the healthcare system and potential for loss of follow-up if test results are not shared with health care professionals or never make it into the medical record.” The editorial also points out ethical and medical issues when minors use these tests. If a child's test is done without medical oversight, results might not be added to their health records, making follow-up care harder to manage and potentially risking their long-term health. Cost is another issue. These tests are often not covered by insurance, which can place a financial burden on families who might need additional testing or medical advice. The researchers emphasize that genetic testing for cancer risk should always include healthcare providers and genetic counseling. This ensures users fully understand their results and receive proper guidance. The authors also call on the US Food and Drug Administration (FDA) to provide clear rules for using these tests, particularly for minors. In conclusion, while genetic testing holds great potential for improving cancer prevention and care, its benefits must not come at the cost of safety and public health. Responsible use of these tests will require collaboration between regulators, healthcare professionals, and testing companies to address the risks and ensure these tools are used effectively. DOI - https://doi.org/10.18632/oncotarget.28677 Correspondence to - Wafik S. El-Deiry - wafik@brown.edu Video short - https://www.youtube.com/watch?v=DjKpiBNDWHo Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Dominique Jean Larrey lived quite a life. He was born in 1766, and at the age of 13, had to walk from his home in a French village to study in the city of Toulouse. That journey was 70 miles, and yes, he walked it. That would be important much later in his life, when he found himself walking through the bitter cold in Russia as the Chief Surgeon of Napoleon's army. During that time, Napoleon's troops had to contend with the reality of Russian cold and temperatures that got as low as -37 degrees Celsius, which is about -35 Fahrenheit.Larrey attributed his ability to withstand the cold to his walking. But many of the soldiers around him wound up with frostbite, and to treat them, Larrey suggested slowly rewarming the affected area and rubbing it with snow. Frostbite treatment has been on quite the journey since then, and it was just earlier this year that the FDA approved the first drug to treat frostbite in the US, which is exciting news for the doctors who see cases of frostbite and for patients who are often left with the horrific reality of amputation. Send us your science stories/factoids/news for a chance to be featured on an upcoming Tiny Show and Tell Us bonus episode and to be entered to win a Tiny Matters coffee mug! And, while you're at it, subscribe to our newsletter at bit.ly/tinymattersnewsletter.Links to the Tiny Show & Tell story are here and here. All Tiny Matters transcripts and references are available here.

Hey how are you doing today? Do you feel good? Are you feeling good about yourself? If not, have I got the product for you - a lil substance you can inject to spawn a hotter version of yourself who will ruin your life. Are you interested?  We're talking THE SUBSTANCE (2024), a very weird and disgusting and delightful film we can not recommend highly enough. Don't cheat yourself out of watching this without spoilers! And ladies, remember - you're more than just one b00b Follow us on Bluesky: https://bsky.app/profile/noshowmonster.bsky.social Follow us on Instagram: https://www.instagram.com/noshowmonster/ Email us at noshowmonster@gmail.com Follow Kelly Attaway Bluesky: https://bsky.app/profile/kellyattaway.bsky.social Instagram: https://www.instagram.com/spooky_kellyyy/ Follow Chelsea Hollander lol SIKE you can't she's not online because she values her mental health and wellbeing  Hosted by Kelly Attaway and Chelsea Hollander Produced by Kelly Attaway Art by Ryan Tate Theme by Unicorn Heads    

Don't let sleep apnea disrupt your nights—or your health—any longer. Texas Sinus & Snoring (346-413-9313) offers a wide range of sleep disorder treatments, including Inspire therapy. Schedule a no-obligation consultation at https://texassinusandsnoring.com/services/sleep-apnea/inspire-sleep-therapy/ to see if Inspire therapy is right for you. Texas Sinus and Snoring City: Spring Address: 2940 Farm to Market 2920 Website: https://texassinusandsnoring.com/ Phone: +1 346 413 9313 Email: Info@texassinusandsnoring.com

The U.S. Food and Drug Administration has approved cannabis-derived medications for several indications. In this episode, family practitioner Randy Easterling, MD, highlights the current regulatory status of FDA-approved cannabis-derived medications and their approved uses.     ⭐⭐⭐⭐⭐

Kate Willis is an esteemed leader in Healthcare and MedTech, known for her strategic prowess and innovative approaches. Currently, she serves as the Vice President of Commercialization at Neurovalens, responsible for leading all global and US commercial functions, including the US launch. Her career highlights include serving as the Director of Government Affairs and Advocacy, where she has been a powerful force in shaping industry standards and policies.Kate's robust track record of leadership extends through premier companies such as Nevro, Medtronic, Nuvasive, and Zimmer Biomet, where her initiatives have not only spurred organizational growth but have also earned her multiple accolades. These honors include prestigious recognitions such as multiple President's Club awards, Sales Rep of the Year, and Rookie of the Year. Beyond her healthcare expertise, Kate is a recognized figure in the arts as a producer and investor, with successful ventures in Broadway, West End, and film productions. Her unique flair for bridging the realms of business and entertainment underlines her diverse capabilities and visionary outlook. SHOWNOTES:

The diagnostic paradigm for Alzheimer's disease (AD) has rapidly shifted in the last five years as fluid-based biomarker testing has emerged as a reliable, accurate, and accessible means to detect amyloid pathology when evaluating a patient for cognitive decline. This podcast is designed to help pathologists and laboratory professionals gain an understanding of plasma testing for markers such as Abeta40/42, P-tau181, and P-tau217 which are rapidly appearing in the commercial space and how healthcare providers have begun incorporating these tests into routine neurology practice. This podcast will help participants to understand the advantages and limitations of these assays as well as their potential application when a physician is evaluating a patient for AD. 

Rexulti. Power of Attorney for NIL. Podcasting, for who?

Guests: Ross O'Neill Ph.D (Founding CEO) & Hubert Lim Ph.D (Chief Scientific Officer) of Neuromod Dave is joined by Ross & Hubert to discuss: - The backstory of how Ross & Hubert met and ultimately partnered together on Lenire - Hubert's research and papers he wrote about paired stimulation & Pavlovian conditioning, which included data that identified tongue stimulation combined with sound as a promising direction to pursue - An overview of what exactly tinnitus is and why Lenire presents such a novel approach to treating tinnitus - Other types of synchronous-stimuli approaches that have emerged in other healthcare verticals (i.e. mirror therapy for phantom limb pain) - The challenging process of gaining FDA approval and the clinical trials that were conducted throughout the process - Being featured as the cover story on Nature Communications - The initial roll-out of Lenire, the current state of the provider network, and the real-world data that's being collected and published

I dive deep into the illusion of safety behind FDA approvals and doctor recommendations. I unpack the shocking reality that the FDA, the very agency tasked with protecting public health, is often funded by the same conglomerates it's supposed to regulate. From fast-tracked pharmaceuticals to harmful food additives like aspartame and glyphosate, I reveal how corporate interests and profit often overshadow genuine concern for our well-being. Exploring conflicts of interest embedded within the system, like the opioid crisis, I challenge the notion that “doctor-recommended” always means safe. I urge you to become your own health advocate, question the system, and reconnect with nature to truly reclaim your health. This episode is a must-listen for anyone ready to break free from blind trust in labels and take control of their wellness journey. Resources:  Puori Supplements discount code: HEALINGTHESOURCE for 20% off your order sitewide (don't miss out PW1 grass-fed protein powder and CP1 collagen!!) Follow the host, Claudia Gilani, here, and check out HealingTheSource.org

Tune in to Episode 18 of the Full-Arch Secrets Podcast, where we speak with Dr. Michael Klein of Keystone Dental Group about the revolutionary Nexus IOS digital art system.In this episode, you'll explore:The challenges of traditional full-arch restoration methods and the need for precisionHow Nexus IOS, an FDA and ISO-certified digital process, reduces treatment time and ensures accurate resultsThe benefits of this technology in improving patient experience with enhanced comfort and aestheticsKeystone's unmatched warranty and commitment to qualityProven success with over 35,000 implants restored using Nexus IOSEpisode 18 is packed with insights to transform your approach and set your practice apart. Don't miss it!Ready to 10X Your Implant Practice?Schedule a FREE Consultation and find out how DIM can help you skyrocket your growth!Get Social With DIM: LinkedInFacebookInstagram

"Explore the revolutionary FDA-approved liver-directed therapy for metastatic uveal melanoma in our latest discussion with Dr. Chmielowski from UCLA. Discover how this groundbreaking treatment is making strides in patient care and what it means for future oncological practices. Learn about the therapy's development, its impact on patient outcomes, and UCLA's role in advancing treatment options. Tune in to uncover how this innovative approach is reshaping the treatment landscape for uveal melanoma."

Let's meet Cathy Goldstein, MD as she talks to SleepTech Talk about some exciting new technology in portable sleep studies. Dr Goldstein was the principle investigator (PI) for validation study Huxley Medical's latest FDA approved portable PSG unit, Sansa. She talks to us about why it's different and how it will help even more patients. Dr Cathy Goldstein is a Professor of Neurology at University of Michigan. She is also an internationally recognized expert in sleep tracking and sleep tracking technology. Dr Goldstein serves as a senior editor of Principles and Practices of Sleep Medicine and holds editorial roles for the Journal of Clinical Sleep Medicine. Listen in as we talk to Dr Goldstein and dive into her wealth of knowledge. A huge thanks to our sponsors: Medbridge Healthcare: For Job Opportunities with MedBridge Healthcare click here: https://medbridgehealthcare.com/careers/ Don't forget to Like, Share, Comment, and Subscribe! Learn more about the show at https://www.sleeptechtalk.com/thetechroom Credits: Audio/ Video: Diego R Mann; Music: Pierce G Mann Hosts: J. Emerson Kerr, Robert Miller, Gerald George Mannikarote Copyright: ⓒ 2024 SleepTech Talk Productions Sleep apnea, OSA, obstructive sleep apnea, dental appliance, oral appliance, oral sleep appliance, inspire, surgery, sleep surgery, CPAP

As of 2019, there are urine-free FDA-approved bioidentical hormones that skirt the standardization concerns of compounded preparations. Are they any safer?

Links and updates for Summer 2024Original post: https://www.experimental-history.com/p/bloodletting-leeches-and-other-fdaAll posts: https://www.experimental-history.com/Music by Brandon Rosiar, photos by my dad

An FDA-approved wonder weight-loss drug that's faster and less side-effect-prone than Semaglutide?! Dr. Kristen is here to spill the hottest tea on Tirzepatide, revealing why this game-changing drug is stealing the spotlight. But wait, it gets even crazier—discover how Tirzepatide is delivering mind-blowing benefits like boosting PCOS fertility and possibly even tackling dementia. Tune in because this revolutionary drug could be the ultimate game-changer for your health and wellness journey! TIMESTAMPS:00:00 Tirzapetide: A miracle weight loss drug?02:45 The shocking differences between Tirzepatide and Semaglutide.03:52 How to avoid the dark side of weight loss drugs.06:44 Dr. Kristen's proven protocol for lasting weight loss success.07:02 Breakthrough benefits of GLP 1 Agonists: What the media isn't telling you.11:55 The future of weight loss: What's next for GLP 1 Agonists? LINKS:FIND US AThttps://www.theperfectdose.net/FOLLOW US ON SOCIAL MEDIA: https://www.instagram.com/the_perfectdose/SUBSCRIBE TO OUR YOUTUBE CHANNEL:https://www.youtube.com/@theperfectdoseThe Perfect Dose Podcast is produced by Live Your Truth Media: https://www.liveyourtruth.media/

Recently, the FDA approved a genetic test for opioid use disorder despite clear opposition from scientists and the FDA advisory panel that had reviewed the evidence. The case demonstrates the space where Pharma's incentive may drive innovation that may not help–or worse, cause harm. Abdul reflects on how genetic essentialism and the wrong incentives can reinforce each other. Than he speaks with Dr. Elizabeth Joniak-Grant, a sociologist and patient advocate who voted against the genetic test. This show would not be possible without the generous support of our sponsors. America Dissected invites you to check them out. This episode was brought to you by: Marguerite Casey Foundation invites you to sign up for their new Summer School program at caseygrants.org/summerschool. Henson Shaving invites you to find the razor that will last you a lifetime. Go to https://hensonshaving.com and enter AD at checkout to get 100 free blades with your purchase. (Note: you must add both the 100-blade pack and the razor for the discount to apply.) Blueland invites you to celebrate Plastic Free July with up to 25% off your Blueland order. Go to Blueland.com/america now for your special limited time offer.

In this episode, Dr. Ellen Marmur explains how different colors of LED light emitted from the MMsphereTM modulate cellular activity, skin physiology, and mood in unique ways. Her patented skincare technology augments the benefits of LED light and includes adaptogens, pre-probiotics and photodynamic actives that respond to LED light. DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

For the first time ever, the FDA has approved an over the counter birth control pill. Jordan D'Nelle discusses the specifics of this groundbreaking progesterone-only birth control method, discussing its benefits, usage, and implications for accessible reproductive health. You can find Jordan D'Nelle on Instagram @jordandnelle. Enhance your self-awareness by acknowledging and understanding your behavior patterns, and foster a deeper connection with your inner self. Get the Unleashing My Power: A Women's Empowerment and Gratitude Journal to reclaim your personal power through the practice of daily gratitude and reflection. Learn more HERE. Follow Jordan D'Nelle on Facebook and Instagram @jordandnelle. Email: JordanDnelle@VaginasVulvasandVibrators.com Support the Vaginas, Vulvas, and Vibrators podcast! Join the Patreon community: patreon.JordanDnelle.com Leave an honest review on iTunes. Your ratings and reviews help this podcast impact more lives! Subscribe to Vaginas, Vulvas, and Vibrators on iTunes if you haven't already! *Disclaimer: This podcast is for informational and/or entertainment purposes only and is not a substitute for medical advice, diagnosis, or treatment. jordandnelle.com --- Support this podcast: https://podcasters.spotify.com/pod/show/jordan-dnelle/support

Dr. Ben Thompson reviews Lenire, an FDA-approved device to treat tinnitus. Get started with Treble Health:Schedule a complimentary telehealth consultation: treble.health/free-telehealth-consultation Take the tinnitus quiz: https://treble.health/tinnitus-quiz-1Download the Ultimate Tinnitus Guide: 2024 Edition: https://treble.health/tinnitus-guide-2024

After a roller coaster of feedback (very high highs, lots of questions, some lows) on her bio identical hormone episode, Claire decided to address it head on. In this episode Claire talks about how patients are confused by the very experts they turn to, and offers her thoughts.

Last month the FDA approved a new treatment for sickle cell disease, the first medical therapy to use CRISPR gene editing technology. It works by identifying the gene or genes causing the disorder, modifying those genes and then returning them to the patient's body.There are now two gene therapies offered by pharmaceutical companies for sickle cell disease: Casgevy from Vertex Pharmaceuticals and CRISPR Therapeutics, and Lyfgenia from BlueBird Bio. But prices for these one-time treatments are steep: Casgevy costs $2.2 million per patient and Lyfgenia $3.1 million.Both promise a full cure, which would be life-changing for patients with this debilitating condition. Over 100,000 Americans, mostly of African descent, have sickle cell disease.This milestone raises more questions: What will be the next disease that CRISPR can help cure? And is it possible to reduce the costs of gene therapy treatments?Ira talks with Dr. Fyodor Urnov, professor of molecular and cell biology and scientific director of technology and translation at the Innovative Genomics Institute, based at the University of California, Berkeley, about the future of CRISPR-based cures.Transcripts for this segment will be available the week after the show airs on sciencefriday.com. To stay updated on all things science, sign up for Science Friday's newsletters.

The death rate for young adult Americans, the people who are supposed to be in peak physical health, has surged abruptly over the past few years. In fact, the surge matches almost exactly with the rollout of Covid vaccines — and vaccine mandates — in early 2021. So when will public officials finally allow people to ask whether the obvious cause is the actual one? Charlie speaks to Dr. Pierre Kory about his op-ed on this surge in deaths, as well as a recent FDA admission that doctors are free to prescribe Ivermectin. Plus, Alan Dershowitz responds to the imminent fourth indictment of Donald Trump, which may be the most outlandish one yet.Support the show: http://www.charliekirk.com/supportSee omnystudio.com/listener for privacy information.